Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study

Patient empowerment and optimal glycemic control

(2012) Russell D. White   CURRENT MEDICAL RESEARCH AND OPINION

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes

(2011) M. Riddle et al.   DIABETES CARE

Postprandial and Basal Glucose in Type 2 Diabetes: Assessment and Respective Impacts

(2011) Louis Monnier et al.   Diabetes Technology & Therapeutics

A Stepwise Approach to Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Basal Insulin Treatment Failure

(2011) Mayer Davidson et al.   Endocrine Practice

The glucose triad and its role in comprehensive glycaemic control: current status, future management

(2010) A. Ceriello   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial

(2009) Jean-Louis Selam et al.   ADVANCES IN THERAPY

Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA1cin subjects with Type 2 diabetes

(2009) R. Peter et al.   DIABETIC MEDICINE

Barriers to insulin initiation and intensification and how to overcome them

(2009) T. Kunt et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient empowerment: Myths and misconceptions

(2009) Robert M. Anderson et al.   PATIENT EDUCATION AND COUNSELING